Todd Asset Management LLC Takes $15.51 Million Position in HCA Healthcare Inc (NYSE:HCA)

Todd Asset Management LLC purchased a new stake in HCA Healthcare Inc (NYSE:HCA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 114,748 shares of the company’s stock, valued at approximately $15,510,000.

Other hedge funds have also recently made changes to their positions in the company. Westside Investment Management Inc. bought a new stake in HCA Healthcare in the 2nd quarter valued at $34,000. NEXT Financial Group Inc bought a new stake in HCA Healthcare in the 2nd quarter valued at $43,000. Rational Advisors LLC lifted its position in HCA Healthcare by 5,118.2% in the 1st quarter. Rational Advisors LLC now owns 574 shares of the company’s stock valued at $75,000 after acquiring an additional 563 shares in the last quarter. Cornerstone Advisors Inc. lifted its position in HCA Healthcare by 19.6% in the 1st quarter. Cornerstone Advisors Inc. now owns 587 shares of the company’s stock valued at $77,000 after acquiring an additional 96 shares in the last quarter. Finally, Alpha Windward LLC lifted its position in HCA Healthcare by 50.9% in the 2nd quarter. Alpha Windward LLC now owns 608 shares of the company’s stock valued at $89,000 after acquiring an additional 205 shares in the last quarter. 70.32% of the stock is owned by institutional investors.

In related news, SVP Robert A. Waterman sold 33,786 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total value of $4,560,434.28. Following the transaction, the senior vice president now owns 279,551 shares in the company, valued at approximately $37,733,793.98. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, major shareholder Patricia F. Elcan purchased 250 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The stock was bought at an average price of $124.10 per share, for a total transaction of $31,025.00. The disclosure for this purchase can be found here. 2.70% of the stock is currently owned by corporate insiders.

Several equities research analysts recently commented on the stock. Mizuho set a $153.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, July 31st. Deutsche Bank boosted their price objective on shares of HCA Healthcare from $160.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. Stephens set a $150.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, August 7th. UBS Group boosted their price objective on shares of HCA Healthcare from $172.00 to $181.00 and gave the company a “buy” rating in a research report on Monday, June 24th. Finally, Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price objective on the stock. in a research report on Monday, May 27th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and seventeen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $153.35.

NYSE:HCA traded down $2.46 on Friday, hitting $119.78. 1,110,797 shares of the company’s stock were exchanged, compared to its average volume of 2,028,713. The firm has a 50-day moving average price of $133.26 and a 200-day moving average price of $130.99. HCA Healthcare Inc has a 52 week low of $110.31 and a 52 week high of $147.42. The company has a market cap of $41.68 billion, a P/E ratio of 12.26, a price-to-earnings-growth ratio of 1.05 and a beta of 0.85.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 30th. The company reported $2.21 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.49 by ($0.28). The firm had revenue of $12.60 billion during the quarter, compared to the consensus estimate of $12.61 billion. HCA Healthcare had a net margin of 7.46% and a negative return on equity of 135.90%. The firm’s revenue for the quarter was up 9.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.29 earnings per share. Research analysts anticipate that HCA Healthcare Inc will post 10.36 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Tuesday, September 3rd will be issued a $0.40 dividend. The ex-dividend date is Friday, August 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.34%. HCA Healthcare’s payout ratio is 16.38%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Do equity income investments outperform growth and income investments?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.